In summary, the response of TLR4 and of TLR2 to SARS-CoV-2 may switch the anti-viral response of the lung from the release of type I IFNs to an exaggerated synthesis of pro-inflammatory mediators, explaining at least in part the hyperinflammation observed in severe COVID-19. This evidence concerns the gene TLR2 and COVID-19.